Old Web
English
Sign In
Acemap
>
authorDetail
>
Julie Pribyl
Julie Pribyl
Pharmacology
Pharmacokinetics
Psychology
Diabetes mellitus
Psychiatry
3
Papers
38
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease
2019
Alzheimer's & Dementia: Translational Research & Clinical Interventions
Michael Grundman
Roger Morgan
Jason Lickliter
Lon S. Schneider
Steven T. DeKosky
Nicholas J. Izzo
Robert Guttendorf
Michelle Higgin
Julie Pribyl
Kelsie Mozzoni
Hank Safferstein
Susan M. Catalano
Show All
Source
Cite
Save
Citations (36)
A PHASE 1 SAFETY TRIAL OF THE Aβ OLIGOMER RECEPTOR ANTAGONIST CT1812
2017
Alzheimers & Dementia
Susan Catalano
Michael Grundman
Lon S. Schneider
Steven T. DeKosky
Roger Morgan
Robert Guttendorf
Michelle Higgin
Julie Pribyl
Kelsie Mozzoni
Nicholas J. Izzo
Hank Safferstein
Show All
Source
Cite
Save
Citations (1)
A TWO-PART, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 1 STUDY OF THE SAFETY AND PHARMACOKINETICS OF SINGLE AND MULTIPLE ASCENDING DOSES OF CT1812 IN HEALTHY VOLUNTEERS
2016
Alzheimers & Dementia
Susan Catalano
Michael Grundman
Lon S. Schneider
Steven T. DeKosky
Roger Morgan
Michelle Higgin
Julie Pribyl
Kelsie Mozzoni
Nicholas J. Izzo
Hank Safferstein
Jason Lickliter
Show All
Source
Cite
Save
Citations (1)
1